Description

Benzyl Alcohol, α-[1-(Ethylamino)Ethyl]-3,4-Dimethyl-, Threo- (8Ci) is a specialized chiral benzyl alcohol derivative with a complex amine-containing side chain. This compound is significant as a high-value pharmaceutical intermediate and a versatile chiral building block for asymmetric synthesis. It is primarily needed by research and development laboratories, fine chemical manufacturers, and pharmaceutical companies engaged in the synthesis of active pharmaceutical ingredients (APIs), particularly those targeting neurological or receptor-specific pathways.

Application

• Pharmaceutical Intermediate: A key chiral precursor in the multi-step synthesis of complex drug molecules and active pharmaceutical ingredients (APIs).
• Asymmetric Synthesis Building Block: Utilized in stereoselective reactions to construct molecules with specific three-dimensional configurations critical for biological activity.
• Chemical Research & Development: Serves as a valuable reference standard and starting material in medicinal chemistry and process development for novel therapeutics.
• Ligand and Catalyst Synthesis: Used in the preparation of chiral ligands and organocatalysts for enantioselective transformations.
• Fine Chemical Production: Employed in the manufacture of specialty chemicals requiring precise stereochemistry and functional group compatibility.

Basic Information

Product Name	Benzyl Alcohol, α-[1-(Ethylamino)Ethyl]-3,4-Dimethyl-, Threo- (8Ci)
CAS No.	802833-50-7
Molecular Formula	C13H21NO
Molecular Weight	207.31 g/mol
Synonyms	α-[1-(Ethylamino)ethyl]-3,4-dimethylbenzyl alcohol, threo-; (1R,2S)- or (1S,2R)-1-(Ethylamino)-1-(3,4-dimethylphenyl)propan-2-ol; 3,4-Dimethyl-α-[1-(ethylamino)ethyl]benzenemethanol, threo-; Threo-Benzyl Alcohol Derivative CAS 802833-50-7; (threo)-1-(3,4-Dimethylphenyl)-1-(ethylamino)propan-2-ol; A Chiral Amino Alcohol Derivative; Potential Intermediate for Drug Synthesis
EINECS	Contact for details

Quality Control

Our Benzyl Alcohol, α-[1-(Ethylamino)Ethyl]-3,4-Dimethyl-, Threo- (8Ci) is produced under strict quality management systems. Each batch undergoes rigorous analytical testing, including chiral purity analysis, to ensure it meets the high standards required for pharmaceutical R&D and fine chemical synthesis. Certificates of Analysis (COA) detailing identity, purity, and impurity profiles are provided and available upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). This compound may be hygroscopic (moisture-sensitive); keep the container tightly sealed under an inert atmosphere if specified.

Specification

Item	Specification
Appearance	White to off-white solid or viscous liquid
Identification (IR)	Conforms to structure
Assay (HPLC)	≥ 95.0%
Chiral Purity (Chiral HPLC)	≥ 98.0% de (threo isomer)
Water Content (KF)	≤ 1.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.